Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer.
brachytherapy
magnetic resonance imaging
prostate cancer
radiotherapy
salvage
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
30
10
2022
accepted:
04
11
2022
entrez:
5
12
2022
pubmed:
6
12
2022
medline:
6
12
2022
Statut:
epublish
Résumé
[This corrects the article DOI: 10.3389/fonc.2022.971344.].
Identifiants
pubmed: 36465337
doi: 10.3389/fonc.2022.1084708
pmc: PMC9714600
doi:
Types de publication
Published Erratum
Langues
eng
Pagination
1084708Commentaires et corrections
Type : ErratumFor
Informations de copyright
Copyright © 2022 Ménard, Navarro-Domenech, Liu, Joseph, Barkati, Berlin, Delouya, Taussky, Beauchemin, Nicolas, Kadoury, Rink, Raman, Sundaramurthy, Weersink, Beliveau-Nadeau, Helou and Chung.